Clinical Trials in Miami

Showing 3521-3540 of 9,821 trials

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

NCT05107882

This observational, cross-sectional study is designed to validate a novel diagnostic test for the detection of phenotypic changes in the retina that correlate with likely PET amyloid status (negative or positive), to aid in the evaluation of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. The CAS test is an adjunct to other diagnostic evaluations, and is indicated for use with the Optina Diagnostics' MHRC (K200254).

Alzheimer DiseaseMild Cognitive ImpairmentMild Dementia

Optina Diagnostics Inc.466 participantsStarted Jun 2022

Miami, Florida, United States • Las Vegas, Nevada, United States • Norfolk, Virginia, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

NCT03902080

This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.

Overactive Bladder

Urovant Sciences GmbH1,105 participantsStarted Mar 2019

Homewood, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +137 more locations

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Find Trials by Condition in Miami

Microwave Treatment for Actinic Keratosis

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Longitudinal Cognitive Assessment by BoCA

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

The clonoSEQ® Watch Registry

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Training for Health Professionals In Tanzania